BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 22315972)

  • 21. TGF-β1 Induces EMT in Bovine Mammary Epithelial Cells Through the TGFβ1/Smad Signaling Pathway.
    Chen Q; Yang W; Wang X; Li X; Qi S; Zhang Y; Gao MQ
    Cell Physiol Biochem; 2017; 43(1):82-93. PubMed ID: 28848180
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of transforming growth factor-beta1-induced signaling and epithelial-to-mesenchymal transition by the Smad-binding peptide aptamer Trx-SARA.
    Zhao BM; Hoffmann FM
    Mol Biol Cell; 2006 Sep; 17(9):3819-31. PubMed ID: 16775010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fucoidan induces changes in the epithelial to mesenchymal transition and decreases metastasis by enhancing ubiquitin-dependent TGFβ receptor degradation in breast cancer.
    Hsu HY; Lin TY; Hwang PA; Tseng LM; Chen RH; Tsao SM; Hsu J
    Carcinogenesis; 2013 Apr; 34(4):874-84. PubMed ID: 23275155
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA.
    Kong W; Yang H; He L; Zhao JJ; Coppola D; Dalton WS; Cheng JQ
    Mol Cell Biol; 2008 Nov; 28(22):6773-84. PubMed ID: 18794355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chimaphilin inhibits human osteosarcoma cell invasion and metastasis through suppressing the TGF-β1-induced epithelial-to-mesenchymal transition markers via PI-3K/Akt, ERK1/2, and Smad signaling pathways.
    Dong F; Liu T; Jin H; Wang W
    Can J Physiol Pharmacol; 2018 Jan; 96(1):1-7. PubMed ID: 28177668
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transforming growth factor beta-induced Smad1/5 phosphorylation in epithelial cells is mediated by novel receptor complexes and is essential for anchorage-independent growth.
    Daly AC; Randall RA; Hill CS
    Mol Cell Biol; 2008 Nov; 28(22):6889-902. PubMed ID: 18794361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
    Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
    BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Soluble MMP-14 produced by bone marrow-derived stromal cells sheds epithelial endoglin modulating the migratory properties of human breast cancer cells.
    Tobar N; Avalos MC; Méndez N; Smith PC; Bernabeu C; Quintanilla M; Martínez J
    Carcinogenesis; 2014 Aug; 35(8):1770-9. PubMed ID: 24618373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SOSTDC1 differentially modulates Smad and beta-catenin activation and is down-regulated in breast cancer.
    Clausen KA; Blish KR; Birse CE; Triplette MA; Kute TE; Russell GB; D'Agostino RB; Miller LD; Torti FM; Torti SV
    Breast Cancer Res Treat; 2011 Oct; 129(3):737-46. PubMed ID: 21113658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. WSZG inhibits BMSC-induced EMT and bone metastasis in breast cancer by regulating TGF-β1/Smads signaling.
    Ma J; Li J; Wang Y; Chen W; Zheng P; Chen Y; Sun Z; Liu J; Zhou Y; Wang J; Liu S; Han X
    Biomed Pharmacother; 2020 Jan; 121():109617. PubMed ID: 31810139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TGF-β Signaling in Cancer.
    Syed V
    J Cell Biochem; 2016 Jun; 117(6):1279-87. PubMed ID: 26774024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ErbB/EGF signaling and EMT in mammary development and breast cancer.
    Hardy KM; Booth BW; Hendrix MJ; Salomon DS; Strizzi L
    J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):191-9. PubMed ID: 20369376
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LMO4 can interact with Smad proteins and modulate transforming growth factor-beta signaling in epithelial cells.
    Lu Z; Lam KS; Wang N; Xu X; Cortes M; Andersen B
    Oncogene; 2006 May; 25(20):2920-30. PubMed ID: 16331278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Cain and Abl of epithelial-mesenchymal transition and transforming growth factor-β in mammary epithelial cells.
    Allington TM; Schiemann WP
    Cells Tissues Organs; 2011; 193(1-2):98-113. PubMed ID: 21051857
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Downregulation of gangliotetraosylceramide and β1,3-galactosyltransferase-4 gene expression by Smads during transforming growth factor β-induced epithelial-mesenchymal transition.
    Guo J; Song B; Li X; Hε C; Yang G; Yang X; Guan F
    Mol Med Rep; 2015 Mar; 11(3):2241-7. PubMed ID: 25384497
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human adipose‑derived mesenchymal stem cells promote breast cancer MCF7 cell epithelial‑mesenchymal transition by cross interacting with the TGF‑β/Smad and PI3K/AKT signaling pathways.
    Wu S; Wang Y; Yuan Z; Wang S; Du H; Liu X; Wang Q; Zhu X
    Mol Med Rep; 2019 Jan; 19(1):177-186. PubMed ID: 30483746
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dihydroartemisinin inhibits the tumorigenesis and metastasis of breast cancer via downregulating CIZ1 expression associated with TGF-β1 signaling.
    Li Y; Zhou X; Liu J; Gao N; Yang R; Wang Q; Ji J; Ma L; He Q
    Life Sci; 2020 May; 248():117454. PubMed ID: 32088211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ZNF217 is a marker of poor prognosis in breast cancer that drives epithelial-mesenchymal transition and invasion.
    Vendrell JA; Thollet A; Nguyen NT; Ghayad SE; Vinot S; Bièche I; Grisard E; Josserand V; Coll JL; Roux P; Corbo L; Treilleux I; Rimokh R; Cohen PA
    Cancer Res; 2012 Jul; 72(14):3593-606. PubMed ID: 22593193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cancer-associated fibroblast-derived Gremlin 1 promotes breast cancer progression.
    Ren J; Smid M; Iaria J; Salvatori DCF; van Dam H; Zhu HJ; Martens JWM; Ten Dijke P
    Breast Cancer Res; 2019 Sep; 21(1):109. PubMed ID: 31533776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. JianPi JieDu Recipe Inhibits Epithelial-to-Mesenchymal Transition in Colorectal Cancer through TGF-
    Liu X; Ji Q; Deng W; Chai N; Feng Y; Zhou L; Sui H; Li C; Sun X; Li Q
    Biomed Res Int; 2017; 2017():2613198. PubMed ID: 28299321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.